ScholarIQanswers from OpenAlex
Cancer-related Molecular Pathways
TopicLeading institutions, researchers & key papers
Cancer-related Molecular Pathways is a topic indexed in ScholarIQ from OpenAlex.
What is known about Cancer-related Molecular Pathways?
ScholarIQrecord summary
This cluster of papers focuses on the p53 signaling network, exploring its role in cell cycle regulation, tumor suppression, cancer therapy, apoptosis, and the impact of mutations. The papers cover various aspects of p53-MDM2 interaction, cyclin-dependent kinases, and the intricate mechanisms of p53 regulation in the context of cancer research.
How many works does Cancer-related Molecular Pathways have?
ScholarIQindexed works
Cancer-related Molecular Pathways has 323 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Cancer-related Molecular Pathways?
ScholarIQopenalex
The OpenAlex for Cancer-related Molecular Pathways is on the source record.
What are the most-cited papers on Cancer-related Molecular Pathways?
ScholarIQmost cited works
p53 Mutations in Human Cancers
Monica Hollstein, David Sidransky, Bert Vogelstein, Curtis C. Harris
A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma.
Douglas E. Brash, Jeffrey A. Rudolph, J A Simon, Amy Lin, Greg J. McKenna, Howard P. Baden, Alan J. Halperin, J Pontén
Dynamics of the p53-Mdm2 feedback loop in individual cells
Galit Lahav, Nitzan Rosenfeld, Alex Sigal, Naama Geva‐Zatorsky, Arnold J. Levine, Michael B. Elowitz, Uri Alon
Cellular mechanisms of tumour suppression by the retinoblastoma gene
Deborah L. Burkhart, Julien Sage
Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.
Ming Liu, Mong‐Hong Lee, Michael B. Cohen, M Bommakanti, Leonard P. Freedman
Where is Cancer-related Molecular Pathways research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Cancer-related Molecular Pathways is open access?
ScholarIQopen access share
53%OPEN ACCESS